ATNM vs ILMN · rev $35.0M vs rev $4.34B
Actinium Pharmaceuticals Inc (ATNM) versus Illumina Inc (ILMN) — a side-by-side from cached financials, not a winner call.
Actinium Pharmaceuticals Inc (ATNM) is a biotechnology company listed on US.
Illumina Inc (ILMN) is a diagnostics & research company listed on US. It is led by Jacob Thaysen Ph.D..
Latest reported ATNM revenue for 2026-06-30 was $35.0M. Net income was $22.4M. Revenue was up 38788.9% from 2025-09-30 to 2026-06-30. ATNM currently screens at market cap $33.9M.
Latest reported ILMN revenue for 2025-12-28 was $4.34B. Net income was $850.0M. ILMN currently screens at market cap $15.84B.
ATNM currently screens at market cap $33.9M. ILMN currently screens at market cap $15.84B.
Not investment advice. Open the ATNM and ILMN stock pages for the full models.
Not investment advice.